2024

• Jiao Q, Lohse K, Rauber-Ellinghaus MM, Kolkhir P, Frischbutter S, Scheffel J, Xiang YK, Maurer M, Altrichter S. (2024) Basophil and eosinophil recruitment to skin lesions is linked to features of autoimmune chronic spontaneous urticaria including basopenia. J Eur Acad Dermatol Venereol. 2024 Jun 24. doi: 10.1111/jdv.20204. Online ahead of print.

• Shurmelova I, Baldyga A, Grekowitz E, Kimeswenger S, Hoetzenecker W, Maurer M, Altrichter S. (2024). Skin reaction patterns in cholinergic urticaria. Allergol International. doi: 10.1016/j.alit.2024.07.008. 

• Puxkandl V, Aigner S, Hoetzenecker W, Altrichter S. Hereditary alpha tryptasemia: elevated tryptase, female sex, thyroid disorders, and anaphylaxis. Front Allergy. 2024 Nov 12;5:1461359. doi: 10.3389/falgy.2024.1461359. eCollection 2024

• Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ; ARROYO Study Investigators. (2024) Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial. Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067.
• Ettinger M, Kimeswenger S, Deli I, Traxler J, Altrichter S, Noack P, Wikstrom JD, Guenova E, Hoetzenecker W. (2024) Darier disease: Current insights and challenges in pathogenesis and management. J Eur Acad Dermatol Venereol. 2024 Nov 28. doi: 10.1111/jdv.20448. 
• Holzgruber J, Martins C, Kulcsar Z, Duplaine A, Rasbach E, Migayron L, Singh P, Statham E, Landsberg J, Boniface K, Seneschal J, Hoetzenecker W, Berdan EL, Ho Sui S, Ramsey MR, Barthel SR, Schatton T. (2024) Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade.Nat Commun. 2024 Aug 26;15(1):7165. doi: 10.1038/s41467-024-51496-2.
• Chang YT, Prompsy P, Kimeswenger S, Tsai YC, Ignatova D, Pavlova O, Iselin C, French LE, Levesque MP, Kuonen F, Bobrowicz M, Brunner PM, Pascolo S, Hoetzenecker W, Guenova E. (2024) MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nat Commun. 2024 Jan 25;15(1):752. doi: 10.1038/s41467-024-45083-8.

• Moñino-Romero S, Kolkhir P, Ohanyan T, Szépfalusi Z, Weller K, Metz M, Scheffel J, Maurer M, Altrichter S. (2024) Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):167-174. doi: 10.1111/jdv.19485. Epub 2023 Sep 9.

2023

• Ettinger, M., Burner, T., Sharma, A., Chang, Y., Lackner, A., Prompsy, P., Deli, I., Traxler, J., Wahl, G., Altrichter, S., Langer, R., Tsai, Y., Varkhande, S., Schoeftner, L., Iselin, C., Gratz, I., Kimeswenger, S., Guenova, E., Hoetzenecker, W. (2023). Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets. Nature Communications. 14. 10.1038/s41467-023-43210-5
• Ettinger, M., Burner, T., Pospischil, I., Traxler, J., Wahl, G., Altrichter, S., Lackner, A., G., Kimeswenger, S., Guenova, E., Hoetzenecker, W. (2023). Targeting of Th17-related cytokines in patients with Darier Disease. 10.1101/2023.01.12.22283857
• Moñino-Romero S, Kolkhir P, Ohanyan T, Szépfalusi Z, Weller K, Metz M, Scheffel J, Maurer M, Altrichter S. (2023) Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.J Eur Acad Dermatol Venereol. 2024 Jan;38(1):167-174. doi: 10.1111/jdv.19485. Epub 2023 Sep 9.

2022

• Ettinger, M., Burner, T., Lackner, A., Schoeftner, L., Holzgruber, J., Gruber, R., Guenova, E., Schuetz‐Bergmayr, M., Fischer, T., Gratz, I., Kimeswenger, S., Hoetzenecker, W. (2022). Precision medicine approach in a rare case of autosomal recessive congenital ichthyosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 20. 10.1111/ddg.14923.

• Altrichter S, Staubach P, Pasha M, Singh B, Chang AT, Bernstein JA, Rasmussen HS, Siebenhaar F, Maurer M. (2022) An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria. J Allergy Clin Immunol. 2022 May;149(5):1683-1690.e7. doi: 10.1016/j.jaci.2021.12.772. Epub 2021 Dec 23.PMID: 34954198

2021

• Altrichter, S., Fok, J. S., Jiao, Q., Kolkhir, P., Pyatilova, P., Moñino Romero, S., Scheffel, J., Siebenhaar, F., Steinert, C., Terhorst-Molawi, D., Xiang, Y., Church, M., Maurer, M. (2021). Total IgE as a Marker for Chronic Spontaneous Urticaria. Allergy, Asthma & Immunology Research. 13. 206-218. 10.4168/aair.2021.13.2.206.

2020

• Kimeswenger, S., Tschandl, P., Noack, P., Hofmarcher, M., Rumetshofer, E., Kindermann, H., Silye, R., Hochreiter, S., Kaltenbrunner, M., Guenova, E., Klambauer, G., Hoetzenecker, W. (2020). Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns. Modern Pathology. 34. 10.1038/s41379-020-00712-7.

• Altrichter S, Zampeli V, Ellrich A, Zhang K, Church MK, Maurer M. (2020) IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria.Allergy. 2020 Dec;75(12):3208-3215. doi: 10.1111/all.14412. Epub 2020 Jun 18.PMID: 32446275

2019

• Kimeswenger, S., Rumetshofer, E., Hofmarcher, M., Tschandl, P., Kittler, H.,& Hochreiter, S.,& Hoetzenecker, W., Klambauer, G. (2019). Detecting cutaneous basal cell carcinomas in ultra-high resolution and weakly labelled histopathological images. Machine Learning for Health Workshop at NeurIPS 2019 

• Maurer M, Hawro T, Krause K, Magerl M, Metz M, Siebenhaar F, Terhorst-Molawi D, Weller K, Zuberbier T, Altrichter S. (2019) Diagnosis and treatment of chronic inducible urticaria. Allergy. 2019 Dec;74(12):2550-2553. doi: 10.1111/all.13878. Epub 2019 Jun 2.PMID: 31102545